BIOMAT Database Logo BIOMAT Database Logo

Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative. 2011

R Mallone, and M Scotto, and C N Janicki, and E A James, and L Fitzgerald-Miller, and R Wagner, and P Gottlieb, and J Thorpe, and N Jospe, and I Durinovic-Bellò, and C Boitard, and O Lou, and C M Dayan, and F S Wong, and
INSERM U986, DeAR Lab Avenir, Saint Vincent de Paul Hospital, and Paris Descartes University, Paris, France. Roberto.Mallone@inserm.fr

BACKGROUND Identification of T-cell reactivity to β-cell antigen epitopes is an important goal for studying pathogenesis and for designing and monitoring of immunotherapeutic interventions in type 1 diabetes (T1D). METHODS We performed a multicentre validation of known human leukocyte antigen (HLA) class I CD8+ T-cell epitopes. To this end, peripheral blood T-cell responses were measured in 35 recently (<2 years) diagnosed HLA-A*02:01+ T1D patients using blind-coded HLA-A2 tetramers (TMrs) and pentamers (PMrs), encompassing two epitopes of preproinsulin (PPI; PPIA12-20 and PPIB10-18) and two epitopes of glutamic acid decarboxylase (GAD; GAD114-122 and GAD536-545). We also compared the readout of TMrs and PMrs with a CD8+ T-cell interferon-γ enzyme-linked immunospot assay. RESULTS Despite the minute frequencies of autoreactive cells detected by TMrs/PMrs, most (73-77%) T1D patients had responses to one or more of the epitopes used. All four epitopes were recognized by T1D patients, with a prevalence ranging from 5 to 25%. TMrs and PMrs detected more positive responses to the β-cell epitopes than CD8+ T-cell interferon-γ enzyme-linked immunospot. However, concordance between positive responses to TMrs and PMrs was limited. CONCLUSIONS Using a multicentre blind-coded setup and three different T-cell assays, we have validated PPI and GAD epitopes as commonly recognized CD8+ T-cell targets in recently diagnosed T1D patients. Both TMrs and PMrs showed higher detection sensitivity than the CD8+ T-cell interferon-γ enzyme-linked immunospot assay. However, there are some important methodological issues that need to be addressed in using these sensitive techniques for detecting low frequency responses.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D011498 Protein Precursors Precursors, Protein
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005968 Glutamate Decarboxylase A pyridoxal-phosphate protein that catalyzes the alpha-decarboxylation of L-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining GAMMA-AMINOBUTYRIC ACID levels in normal nervous tissues. The brain enzyme also acts on L-cysteate, L-cysteine sulfinate, and L-aspartate. EC 4.1.1.15. Glutamate Carboxy-Lyase,Glutamic Acid Decarboxylase,Acid Decarboxylase, Glutamic,Carboxy-Lyase, Glutamate,Decarboxylase, Glutamate,Decarboxylase, Glutamic Acid,Glutamate Carboxy Lyase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015234 HLA-A Antigens Polymorphic class I human histocompatibility (HLA) surface antigens present on almost all nucleated cells. At least 20 antigens have been identified which are encoded by the A locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts. Antigens, HLA-A,HLA-A,Antigens, HLA A,HLA A Antigens
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I

Related Publications

R Mallone, and M Scotto, and C N Janicki, and E A James, and L Fitzgerald-Miller, and R Wagner, and P Gottlieb, and J Thorpe, and N Jospe, and I Durinovic-Bellò, and C Boitard, and O Lou, and C M Dayan, and F S Wong, and
Immunology of Diabetes Society T-Cell Workshop: HLA class II tetramer-directed epitope validation initiative.
November 2011, Diabetes/metabolism research and reviews,
R Mallone, and M Scotto, and C N Janicki, and E A James, and L Fitzgerald-Miller, and R Wagner, and P Gottlieb, and J Thorpe, and N Jospe, and I Durinovic-Bellò, and C Boitard, and O Lou, and C M Dayan, and F S Wong, and
British Society for Immunology--epitope mapping workshop.
March 1993, Immunology today,
R Mallone, and M Scotto, and C N Janicki, and E A James, and L Fitzgerald-Miller, and R Wagner, and P Gottlieb, and J Thorpe, and N Jospe, and I Durinovic-Bellò, and C Boitard, and O Lou, and C M Dayan, and F S Wong, and
HLA class I epitope discovery in type 1 diabetes: independent and reproducible identification of proinsulin epitopes of CD8 T cells--report of the IDS T Cell Workshop Committee.
October 2006, Annals of the New York Academy of Sciences,
R Mallone, and M Scotto, and C N Janicki, and E A James, and L Fitzgerald-Miller, and R Wagner, and P Gottlieb, and J Thorpe, and N Jospe, and I Durinovic-Bellò, and C Boitard, and O Lou, and C M Dayan, and F S Wong, and
Standardization of T-cell assays in Type I diabetes. Immunology of Diabetes Society T-cell Committee.
May 1999, Diabetologia,
R Mallone, and M Scotto, and C N Janicki, and E A James, and L Fitzgerald-Miller, and R Wagner, and P Gottlieb, and J Thorpe, and N Jospe, and I Durinovic-Bellò, and C Boitard, and O Lou, and C M Dayan, and F S Wong, and
HLA class I epitope discovery in type 1 diabetes.
October 2006, Annals of the New York Academy of Sciences,
R Mallone, and M Scotto, and C N Janicki, and E A James, and L Fitzgerald-Miller, and R Wagner, and P Gottlieb, and J Thorpe, and N Jospe, and I Durinovic-Bellò, and C Boitard, and O Lou, and C M Dayan, and F S Wong, and
Combinatorial detection of autoreactive CD8+ T cells with HLA-A2 multimers: a multi-centre study by the Immunology of Diabetes Society T Cell Workshop.
March 2018, Diabetologia,
R Mallone, and M Scotto, and C N Janicki, and E A James, and L Fitzgerald-Miller, and R Wagner, and P Gottlieb, and J Thorpe, and N Jospe, and I Durinovic-Bellò, and C Boitard, and O Lou, and C M Dayan, and F S Wong, and
Identification of a beta-cell-specific HLA class I restricted epitope in type 1 diabetes.
November 2003, Diabetes,
R Mallone, and M Scotto, and C N Janicki, and E A James, and L Fitzgerald-Miller, and R Wagner, and P Gottlieb, and J Thorpe, and N Jospe, and I Durinovic-Bellò, and C Boitard, and O Lou, and C M Dayan, and F S Wong, and
Preliminary report of the American Society for Histocompatibility and Immunogenetics phase I workshop on HLA class I public epitopes.
February 1987, Transplantation proceedings,
R Mallone, and M Scotto, and C N Janicki, and E A James, and L Fitzgerald-Miller, and R Wagner, and P Gottlieb, and J Thorpe, and N Jospe, and I Durinovic-Bellò, and C Boitard, and O Lou, and C M Dayan, and F S Wong, and
A mini meta-analysis of studies on CD4+CD25+ T cells in human type 1 diabetes: report of the Immunology of Diabetes Society T Cell Workshop.
October 2006, Annals of the New York Academy of Sciences,
R Mallone, and M Scotto, and C N Janicki, and E A James, and L Fitzgerald-Miller, and R Wagner, and P Gottlieb, and J Thorpe, and N Jospe, and I Durinovic-Bellò, and C Boitard, and O Lou, and C M Dayan, and F S Wong, and
Characterization of CD8(-) HLA class I/epitope tetrameric complexes binding T cells.
January 2002, Journal of immunotherapy (Hagerstown, Md. : 1997),
Copied contents to your clipboard!